02.02.12
Nu Skin Enterprises, Inc. posted a 13% rise in annual revenue of $1.74 billion, according to the company. For the fourth quarter, sales rose 23% to
$495.3 million.
"We are extremely pleased with our quarterly and 2011 results," said Truman Hunt, president and chief executive officer. "By all measures, 2011 was a record year. We're also optimistic that our momentum will continue into 2012 as we roll out our latest product innovations globally. Our ageLOC super-class of anti-aging products continues to be a growth catalyst as demonstrated by the tremendously successful limited-time offers of the ageLOC Galvanic Body Spa and ageLOC R2 (R-squared) in the fourth quarter.
"In addition to the energy surrounding ageLOC, we are pleased with growth in the sales force, particularly in the Greater China and South Asia/Pacific regions, as well as in South Korea.
Fourth-quarter revenue in North Asia grew 13% to $204.3 million, while revenue in Greater China improved 66% to $110.6 million. The Americas increased 25% to $76.9 million, while South Asia/Pacific rose 27% to $65.2 million.
Fourth-quarter revenue in Europe was $38.3 million, an 8% decrease over the prior year.
"We closed out 2011 on a high note and anticipate another record year in 2012," said Hunt. "Our primary growth driver for 2012 will be the global roll out of our new ageLOC products. We launched these products in the Americas, North Asia and Europe regions in January and will continue the rollouts in the Greater China and South Asia/Pacific regions in the second and third quarters.
"Emerging markets continue to generate strong results with particularly impressive growth in the Greater China and South Asia/Pacific regions. Our initiatives are driving solid growth in our distributor force as evidenced by healthy gains in both our active and executive distributor numbers, reflecting our compelling business opportunity and fueling our optimism for the future. Overall, we are pleased with the continued positive direction of the business and we believe that we are on track to produce another record year in 2012," concluded Hunt.
$495.3 million.
"We are extremely pleased with our quarterly and 2011 results," said Truman Hunt, president and chief executive officer. "By all measures, 2011 was a record year. We're also optimistic that our momentum will continue into 2012 as we roll out our latest product innovations globally. Our ageLOC super-class of anti-aging products continues to be a growth catalyst as demonstrated by the tremendously successful limited-time offers of the ageLOC Galvanic Body Spa and ageLOC R2 (R-squared) in the fourth quarter.
"In addition to the energy surrounding ageLOC, we are pleased with growth in the sales force, particularly in the Greater China and South Asia/Pacific regions, as well as in South Korea.
Fourth-quarter revenue in North Asia grew 13% to $204.3 million, while revenue in Greater China improved 66% to $110.6 million. The Americas increased 25% to $76.9 million, while South Asia/Pacific rose 27% to $65.2 million.
Fourth-quarter revenue in Europe was $38.3 million, an 8% decrease over the prior year.
"We closed out 2011 on a high note and anticipate another record year in 2012," said Hunt. "Our primary growth driver for 2012 will be the global roll out of our new ageLOC products. We launched these products in the Americas, North Asia and Europe regions in January and will continue the rollouts in the Greater China and South Asia/Pacific regions in the second and third quarters.
"Emerging markets continue to generate strong results with particularly impressive growth in the Greater China and South Asia/Pacific regions. Our initiatives are driving solid growth in our distributor force as evidenced by healthy gains in both our active and executive distributor numbers, reflecting our compelling business opportunity and fueling our optimism for the future. Overall, we are pleased with the continued positive direction of the business and we believe that we are on track to produce another record year in 2012," concluded Hunt.